SynDevRx Obtains $9,093,899 New Financing Round

  • Feed Type
  • Date
    9/16/2015
  • Company Name
    SynDevRx
  • Mailing Address
    One Broadway 14th Floor Cambridge, MA 02142 USA
  • Company Description
    Our mission is to improve human health by developing polymeric prodrugs which deliver MetAP2 inhibitors to diseased tissues. The first two drug candidates we are developing have been previously shown to shrink tumors, inhibit angiogenesis and prevent metastasis in early clinical trials.
  • Website
    http://www.syndevrx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $9,093,899
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy